Published in Gut on March 08, 2013
Comments on 'Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia' by Vanheel et al. Gut (2014) 1.06
Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia. Am J Gastroenterol (2015) 1.04
Functional dyspepsia: new insights into pathogenesis and therapy. Korean J Intern Med (2016) 0.92
Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2016) 0.89
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil (2015) 0.87
Gastrointestinal mucosal barrier function and diseases. J Gastroenterol (2016) 0.85
Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia. Am J Gastroenterol (2014) 0.81
A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction. PLoS One (2014) 0.81
Eosinophilic Gastroenteritis: An Underdiagnosed Condition. Dig Dis Sci (2016) 0.79
Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability. Gastroenterol Res Pract (2016) 0.79
Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clin Transl Gastroenterol (2017) 0.77
From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders. PLoS One (2014) 0.76
Editorial: Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications. Am J Gastroenterol (2017) 0.75
Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study. Sci Rep (2016) 0.75
Authors' response: Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut (2014) 0.75
Functional Dyspepsia: Advances in Diagnosis and Therapy. Gut Liver (2017) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Gastroenterology (2017) 0.75
Early intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment. Sci Rep (2017) 0.75
Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia. Dig Dis Sci (2016) 0.75
The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study. Digestion (2017) 0.75
Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis? J Neurogastroenterol Motil (2017) 0.75
Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol (2017) 0.75
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
Coordinated regulation of Arabidopsis thaliana development by light and gibberellins. Nature (2008) 4.71
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell (2008) 4.01
Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35
The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol (2004) 3.25
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol (2007) 3.24
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology (2014) 3.23
The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol (2012) 3.11
Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 3.11
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol (2013) 2.98
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol (2009) 2.10
Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest (2011) 2.10
Pro: Impedance testing is useful in the management of GERD. Am J Gastroenterol (2009) 2.09
Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol (2004) 2.01
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Reproducibility and agreement of pharyngeal automated impedance manometry with videofluoroscopy. Clin Gastroenterol Hepatol (2011) 1.84
A novel method for the nonradiological assessment of ineffective swallowing. Am J Gastroenterol (2011) 1.81
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut (2010) 1.77
Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci U S A (2011) 1.69
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut (2006) 1.60
Nerve activity recordings in routine human intestinal biopsies. Gut (2012) 1.59
Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology (2005) 1.58
Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol (2005) 1.56
Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol (2006) 1.52
Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol (2013) 1.50
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol (2004) 1.50
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut (2012) 1.49
Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology (2007) 1.48
Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology (2005) 1.46
Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol (2005) 1.44
Quality of medical education in Mexico. Lancet (2004) 1.40
A method to objectively assess swallow function in adults with suspected aspiration. Gastroenterology (2011) 1.35
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32
Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31
Correction for phylogeny, small number of observations and data redundancy improves the identification of coevolving amino acid pairs using mutual information. Bioinformatics (2009) 1.30
Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. Am J Gastroenterol (2007) 1.30
Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 1.29
Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med (2007) 1.28
Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci (2006) 1.28
DWA1 and DWA2, two Arabidopsis DWD protein components of CUL4-based E3 ligases, act together as negative regulators in ABA signal transduction. Plant Cell (2010) 1.28
Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol (2008) 1.28
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26
Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol (2009) 1.26
Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology (2008) 1.22
Arabidopsis transcription factor ELONGATED HYPOCOTYL5 plays a role in the feedback regulation of phytochrome A signaling. Plant Cell (2010) 1.22
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis (2010) 1.22
Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med (2008) 1.21
Dyspepsia: organic versus functional. J Clin Gastroenterol (2012) 1.20
Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology (2003) 1.17
A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol (2011) 1.17
Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am (2011) 1.15
Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol (2012) 1.14
The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med (2008) 1.14
Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.12
The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol (2008) 1.11
Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci (2002) 1.11
Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut (2007) 1.11
Antibiotic therapy for the irritable bowel syndrome. N Engl J Med (2011) 1.09
Pathophysiology of functional dyspepsia. Best Pract Res Clin Gastroenterol (2004) 1.08
Imaging neuron-glia interactions in the enteric nervous system. Front Cell Neurosci (2013) 1.08
Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol (2012) 1.07
TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol (2011) 1.07
Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol (2009) 1.07
Pathogenesis of dyspepsia. Dig Dis (2008) 1.07
Upper esophageal sphincter impedance as a marker of sphincter opening diameter. Am J Physiol Gastrointest Liver Physiol (2012) 1.07
Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol (2008) 1.07
Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm Bowel Dis (2009) 1.06
Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol (2004) 1.05
Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci (2008) 1.04
Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol (2011) 1.03
Functional dyspepsia: past, present, and future. J Gastroenterol (2008) 1.03
Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterol (2011) 1.03
Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations. Clin Pharmacokinet (2011) 1.02
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood (2011) 1.02
Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology (2007) 1.02
Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways. Am J Gastroenterol (2006) 1.01
Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans. J Clin Invest (2011) 1.01
Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol (2004) 1.00
Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil (2010) 0.99
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99